EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Osteoblast‐CD4 + CTL Crosstalk Mediated by SIRT1/DAAM2 Axis Prevents Age‐Related Bone Loss

Bin Yang, Guofu Zhang, Yizhou Zhu, Jingcheng Wang, Xinmin Feng, Wenyong Fei, Jihang Dai, Le Hu, Yi Zhang, Jun Cai, Binjia Ruan, Yue Jin und 9 weitere

Advanced Science · 2025-10 · 12 (39)

DOI: 10.1002/advs.202501170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 26.07.2025. Verfasst von Bin Yang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, 225001, China. Hauptthemen laut MEDLINE: Sirtuin 1, Osteoblasts, T-Lymphocytes, Cytotoxic, Osteoporosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Frontier Technology Research and Development Program of Jiangsu Province, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The dynamic production and clearance of senescent osteoblasts affects bone homeostasis and health. However, the relationship between senescent osteoblasts and the immune system remains unclear. Here, a landscape of the interaction between immune cells and osteoblasts through spatial analysis of the bone microenvironment is presented. Sirtuin 1 (SIRT1), a longevity gene, regulates bone mass maintenance through a mechanism involving osteoblast‐CD4 + cytotoxic T lymphocyte (CTL) crosstalk. In the osteoblastic niche, SIRT1 promotes the secretion of crucial chemokines, such as C‐C motif chemokine ligand 3 (CCL3), C‐C motif chemokine ligand 5 (CCL5), and C‐X‐C motif chemokine ligand 10 (CXCL10), by upregulating dishevelled‐associated activator of morphogenesis 2 (DAAM2) through the acetylation of enhancer of zeste homolog 2 (EZH2), activating and recruiting CD4 + CTLs that eliminate senescent osteoblasts in a major histocompatibility complex class II (MHC‐II)‐dependent manner, slowing the bone ageing process and ameliorating osteoporosis. DAAM2 serves as a pivotal downstream effector for SIRT1 to exert immune‐regulatory effects in the bone microenvironment; thus, targeting DAAM2 can treat osteoporosis by increasing CD4 + CTL responses. These results will facilitate the development of customised therapies targeting senescent osteoblasts to maintain bone health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sirtuin 1OsteoblastsT-Lymphocytes, CytotoxicOsteoporosisCD4-Positive T-LymphocytesAnimalsMiceHumansMice, Inbred C57BL

Stichwörter der Autor:innen

CD4+ cytotoxic T lymphocyteDAAM2SIRT1bone homeostasischemokine signallingosteoblastosteoporosis

Substanzen

Sirtuin 1Sirt1 protein, mouseSIRT1 protein, human

Autor:innen und Institutionen

  • Department of Orthopaedics, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, 225001, China.
  • Northern Jiangsu People's Hospital, Yangzhou, 225001, China.
  • Northern Jiangsu People's Hospital, Clinical Teaching Hospital of Medical School, Nanjing University, Yangzhou, 225001, China.
  • Department of Orthopaedics and Traumatology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, 999077, China.
  • Department of Medical Research Center, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, 225001, China.
  • The Yangzhou School of Clinical Medicine of Dalian Medical University, Yangzhou, 225001, China.

ORCID-Profile: Kelvin Wai Kwok Yeung

Förderung

  • Frontier Technology Research and Development Program of Jiangsu Province
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province
  • Lvyang Jinfeng Talent Project of Yangzhou City

Zitieren

APA

Yang, B., Zhang, G., Zhu, Y., Wang, J., Feng, X., Fei, W., Dai, J., Hu, L., Zhang, Y., Cai, J., Ruan, B., Jin, Y., Wei, F., Lu, G., Wang, D., Cheung, J. P. Y., Shea, G. K. H., Chen, H., Yeung, K. W. K., …, & Wang, Y. (2025). Osteoblast‐CD4 + CTL Crosstalk Mediated by SIRT1/DAAM2 Axis Prevents Age‐Related Bone Loss. Advanced Science, 12(39). https://doi.org/10.1002/advs.202501170

Vancouver

Yang B, Zhang G, Zhu Y, Wang J, Feng X, Fei W, et al. Osteoblast‐CD4 + CTL Crosstalk Mediated by SIRT1/DAAM2 Axis Prevents Age‐Related Bone Loss. Advanced Science. 2025;12(39). doi:10.1002/advs.202501170

BibTeX
@article{Yang2025,
  author = {Yang, Bin and Zhang, Guofu and Zhu, Yizhou and Wang, Jingcheng and Feng, Xinmin and Fei, Wenyong and Dai, Jihang and Hu, Le and Zhang, Yi and Cai, Jun and Ruan, Binjia and Jin, Yue and Wei, Fanhao and Lu, Gang and Wang, Dongan and Cheung, Jason Pui Yin and Shea, Graham Ka Hon and Chen, Hao and Yeung, Kelvin Wai Kwok and Wang, Lei and Wang, Yongxiang},
  title = {Osteoblast‐CD4 + CTL Crosstalk Mediated by SIRT1/DAAM2 Axis Prevents Age‐Related Bone Loss},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {39},
  doi = {10.1002/advs.202501170}
}
Kostenlos starten →